Back to top
more

SeaSpine Holdings Corporation (SPNE)

(Delayed Data from NSDQ)

$15.36 USD

15.36
60,781

+0.73 (4.99%)

Updated May 3, 2019 04:00 PM ET

After-Market: $15.40 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

PerkinElmer (PKI) Q4 Earnings and Revenues Beat Estimates

by Zacks Equity Research

PerkinElmer's (PKI) Q4 earnings benefits from higher revenues and growth in DAS and Diagnostics segments. However, forex remains a woe.

Hill-Rom's (HRC) Q1 Earnings Top Estimates, Revenues In Line

by Zacks Equity Research

Sales in Hill-Rom's (HRC) Surgical Solutions suffer a massive setback, thanks to the divestiture of surgical consumables.

Moving Average Crossover Alert: SeaSpine

by Zacks Equity Research

SeaSpine Holdings Corporation (SPNE) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.

SeaSpine Holdings (SPNE) Reports Q3 Loss, Tops Revenue Estimates

by Zacks Equity Research

SeaSpine (SPNE) delivered earnings and revenue surprises of -27.50% and 3.66%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

SeaSpine Holdings (SPNE) Reports Q2 Loss, Tops Revenue Estimates

by Zacks Equity Research

SeaSpine (SPNE) delivered earnings and revenue surprises of 7.32% and 0.92%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

SeaSpine Holdings (SPNE) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

by Zacks Equity Research

SeaSpine (SPNE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Will SeaSpine Holdings (SPNE) Report Negative Q2 Earnings? What You Should Know

by Zacks Equity Research

SeaSpine (SPNE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

SeaSpine Holdings (SPNE) Reports Q1 Loss, Tops Revenue Estimates

by Zacks Equity Research

SeaSpine (SPNE) delivered earnings and revenue surprises of -14.29% and 1.20%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

Will SeaSpine Holdings (SPNE) Report Negative Earnings Next Week? What You Should Know

by Zacks Equity Research

SeaSpine (SPNE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

SeaSpine Holdings (SPNE) Reports Q3 Loss, Tops Revenue Estimates

by Zacks Equity Research

SeaSpine (SPNE) delivered earnings and revenue surprises of -22.64% and 0.76%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

SeaSpine Holdings (SPNE) Expected to Beat Earnings Estimates: Should You Buy?

by Zacks Equity Research

SeaSpine (SPNE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

The Zacks Analyst Blog Highlights: BioLife Solutions, SeaSpine Holdings, Apollo Endosurgery and CareDx

by Zacks Equity Research

The Zacks Analyst Blog Highlights: BioLife Solutions, SeaSpine Holdings, Apollo Endosurgery and CareDx

    4 Top-Ranked Growth Stocks in MedTech Under $20

    by Zacks Equity Research

    In the wake of the turbulent political scenario and banking on favorable metrics, these four MedTech stocks stand out as the most suitable picks.

      4 Top Growth Picks to Avoid Tax Tangle in MedTech

      by Zacks Equity Research

      Despite the ongoing tax bill-related disputes in the MedTech industry, these stocks with high growth potential can be great bets for investors.

        The Zacks Analyst Blog Highlights: Thermo Fisher Scientific, SeaSpine Holdings and EnteroMedics

        by Zacks Equity Research

        The Zacks Analyst Blog Highlights: Thermo Fisher Scientific, SeaSpine Holdings and EnteroMedics

          4 Momentum Stocks That May Survive the Health Policy Mess

          by Zacks Equity Research

          In view of the current political scenario and banking on favorable metrics, these four MedTech stocks stand out as the most suitable momentum picks.